Instituto de Investigación Sanitaria del Hospital Universitario La Paz-ko ikertzaileekin lankidetzan egindako argitalpenak (8)

2024

  1. Resolvin D2 prevents vascular remodeling, hypercontractility and endothelial dysfunction in obese hypertensive mice through modulation of vascular and proinflammatory factors

    Biomedicine and Pharmacotherapy, Vol. 174

2022

  1. Microsomal prostaglandin E synthase-1 is involved in the metabolic and cardiovascular alterations associated with obesity

    British Journal of Pharmacology, Vol. 179, Núm. 11, pp. 2733-2753

2018

  1. The impact of obesity in the cardiac lipidome and its consequences in the cardiac damage observed in obese rats

    Clinica e Investigacion en Arteriosclerosis, Vol. 30, Núm. 1, pp. 10-20

2017

  1. The role of oxidative stress in the crosstalk between leptin and mineralocorticoid receptor in the cardiac fibrosis associated with obesity

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension

    British Journal of Pharmacology, Vol. 173, Núm. 9, pp. 1541-1555

2015

  1. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension

    British Journal of Pharmacology, Vol. 172, Núm. 12, pp. 3159-3176

2013

  1. Mercury induces proliferation and reduces cell size in vascular smooth muscle cells through MAPK, oxidative stress and cyclooxygenase-2 pathways

    Toxicology and Applied Pharmacology, Vol. 268, Núm. 2, pp. 188-200

2011

  1. Endothelial dysfunction of rat coronary arteries after exposure to low concentrations of mercury is dependent on reactive oxygen species

    British Journal of Pharmacology, Vol. 162, Núm. 8, pp. 1819-1831